Dr Reddys Laboratories Ltd Drl
Business  /  Published 20.05.22

DRL profit falls 76%

“We will continue to focus on growing our core businesses, invest in future growth drivers and work towards greater integration of sustainability in our businesses,’’ G.V. Prasad, co...
By Our Special Correspondent in Mumbai

Business  /  Published 29.01.22

Kotak Bank profit takes 31% jump

Private sector lender Kotak Mahindra Bank on Friday reported a 30.79 per cent jump in its consolidated December quarter net profit at Rs 3,402.74 crore, helped by an all-round performance across subsi...
By The Telegraph in Mumbai

India  /  Published 29.12.21

Nod for drug and two new vaccines

India has added two new vaccines and an early-use anti-viral drug to its armoury to fight Covid-19, all three products based on core technologies developed in the US but produced in India. The Centra...
By G.S. Mudur in New Delhi

Business  /  Published 28.07.21

Dr Reddy’s Lab plays spoilsport

Dr Reddy’s Laboratories (DRL) on Tuesday disappointed the Street as it reported a 36 per cent drop in net profit for the first quarter ended June 30.  The Hyderabad-based pharma major also...
By Our Special Correspondent in Mumbai

India  /  Published 16.06.21

Sputnik V to be available in 9 more cities

Dr Reddys Laboratories which has soft-launched Russias COVID-19 vaccine Sputnik V here has expanded the pilot which is in the final leg to other cities such as Mumbai, Bangalore and New Delhi. P...
By Our Bureau and Agencies in Hyderabad


Business  /  Published 30.03.21

Russian vaccine on DRL radar

Dr Reddy’s Laboratories expects Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks. “We expect to get the approval in the next few weeks...
By Our Bureau in Mumbai

Business  /  Published 18.11.20

Pfizer to sue Indian drug duo

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma and Dr Reddy’s Laboratories alleging that the Indian drug makers were planning separately to come out w...
By PTI in Hyderabad

Opinion  /  Published 13.11.20

Dark web: Cyber attacks on pharmaceuticals

Public health has been compromised by the pandemic. The health of pharmaceutical companies is under threat too, but from a different kind of source. The Indian pharmaceutical company, Lupin, is the la...
By The Editorial Board

India  /  Published 18.10.20

Go-ahead for Russian vaccine trials in India

By G.S. Mudur in New Delhi

Business  /  Published 04.06.19

Pharma faces US price pressure

A raft of measures adopted by the US government to enhance the availability of drugs are impacting the margins of the Indian companies.Hyderabad-based Dr Reddy’s Laboratories (DRL) has said it expec...
By Our Special Correspondent in Mumbai


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.